BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37831277)

  • 1. Luminal A Versus B After Choosing Wisely: Does Lymph Node Surgery Affect Oncologic Outcomes?
    Ong C; Blue CM; Khan J; Deng X; Bandyopadhyay D; Louie RJ; McGuire KP
    Ann Surg Oncol; 2024 Jan; 31(1):335-343. PubMed ID: 37831277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor-Positive Breast Cancer.
    Carleton N; Zou J; Fang Y; Koscumb SE; Shah OS; Chen F; Beriwal S; Diego EJ; Brufsky AM; Oesterreich S; Shapiro SD; Ferris R; Emens LA; Tseng G; Marroquin OC; Lee AV; McAuliffe PF
    JAMA Netw Open; 2021 Apr; 4(4):e216322. PubMed ID: 33856473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of sentinel lymph node biopsy in elderly patients with breast cancer - 10-year experience from a Swiss university hospital.
    Heidinger M; Maggi N; Dutilh G; Mueller M; Eller RS; Loesch JM; Schwab FD; Kurzeder C; Weber WP
    World J Surg Oncol; 2023 Jun; 21(1):176. PubMed ID: 37287038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis.
    Fan YJ; Li JC; Zhu DM; Zhu HL; Zhao Y; Zhu XB; Wu G; Bai TT
    BMC Surg; 2023 Jul; 23(1):209. PubMed ID: 37495945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of omission of axillary lymph node dissection after negative sentinel lymph node biopsy: 70-month follow-up.
    Kim HJ; Son BH; Lim WS; Seo JY; Koh BS; Lee JW; Gong GY; Ahn SH
    Ann Surg Oncol; 2010 Aug; 17(8):2126-31. PubMed ID: 20162458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Early-Stage Breast Cancer Patients with Sentinel Lymph Node Metastasis with and without Completion Axillary Lymph Node Dissection: A Systematic Review and Meta-Analysis.
    Heiranizadeh N; Rafiei Shahamabadi M; Dehghan HR; Jafari-Nedooshan J; Kargar S; Zare M; Amooei A; Shiryazdi SM; Broomand MA; Moravej MT; Sadri Z
    Asian Pac J Cancer Prev; 2022 Aug; 23(8):2561-2571. PubMed ID: 36037108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel Node Biopsy Should Not be Routine in Older Patients with ER-Positive HER2-Negative Breast Cancer Who Are Willing and Able to Take Hormone Therapy.
    McKevitt E; Cheifetz R; DeVries K; Laws A; Warburton R; Gondara L; Lohrisch C; Nichol A
    Ann Surg Oncol; 2021 Oct; 28(11):5950-5957. PubMed ID: 33817760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study.
    Cabıoğlu N; Karanlık H; Yıldırım N; Müslümanoğlu M; Çakmak Karadeniz G; Trabulus Can D; Tükenmez M; Ersoy YE; Uras C; Zengel B; Emiroğlu S; Polat AK; Yeniay L; Özkurt E; Kara H; İbiş K; Aydıner A; Özmen V; İğci A
    Eur J Surg Oncol; 2021 Oct; 47(10):2506-2514. PubMed ID: 34217580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival in patients with node-positive breast cancer who undergo sentinel lymph node biopsy alone after neoadjuvant chemotherapy: meta-analysis.
    Keelan S; Boland MR; Ryan ÉJ; Moran LR; Davey MG; Lloyd AJ; Elwahab S; Hill ADK
    Br J Surg; 2023 Feb; 110(3):324-332. PubMed ID: 36512473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is repeat sentinel lymph node biopsy possible for surgical axillary staging among patients with ipsilateral breast tumor recurrence?
    Lu X; He M; Yu L; Gou Z
    Cancer; 2023 May; 129(10):1492-1501. PubMed ID: 36807239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis.
    Park S; Park JM; Cho JH; Park HS; Kim SI; Park BW
    Ann Surg Oncol; 2013 Sep; 20(9):2858-65. PubMed ID: 23645483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axilla lymph node dissection can be safely omitted in patients with 1-2 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis.
    Gao W; Lu S; Zeng Y; Chen X; Shen K
    Breast Cancer Res Treat; 2022 Nov; 196(1):129-141. PubMed ID: 36076127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Male Breast Cancer and the Application of Sentinel Lymph Node Biopsy: A Multicenter Retrospective Study.
    Shang Q; Feng K; Wei Y; Wang K; Yang C; Zhao S; Liu J; Meng X; Li Y; Du C; Wang J; Qiao G; Li J; Wang X; Wang X
    Oncologist; 2023 Dec; 28(12):e1170-e1178. PubMed ID: 37399228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.
    Gentilini OD; Botteri E; Sangalli C; Galimberti V; Porpiglia M; Agresti R; Luini A; Viale G; Cassano E; Peradze N; Toesca A; Massari G; Sacchini V; Munzone E; Leonardi MC; Cattadori F; Di Micco R; Esposito E; Sgarella A; Cattaneo S; Busani M; Dessena M; Bianchi A; Cretella E; Ripoll Orts F; Mueller M; Tinterri C; Chahuan Manzur BJ; Benedetto C; Veronesi P;
    JAMA Oncol; 2023 Nov; 9(11):1557-1564. PubMed ID: 37733364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of completion axillary dissection for patients with cT1-2N0 breast cancer undergoing total mastectomy with positive sentinel lymph nodes.
    Schwieger L; Postlewait LM; Subhedar PD; Geng F; Liu Y; Gillespie T; Arciero CA
    J Surg Oncol; 2024 Mar; 129(3):468-480. PubMed ID: 37955191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study.
    Zheng Q; Luo H; Xia W; Lu Q; Jiang K; Hong R; Xu F; Wang S
    Breast Cancer Res Treat; 2022 Dec; 196(3):613-622. PubMed ID: 36207619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncological Safety of Skipping Axillary Lymph Node Dissection in Patients with Clinical N0, Sentinel Node-Positive Breast Cancer Undergoing Total Mastectomy.
    Chun JW; Kang E; Kim HK; Lee HB; Moon HG; Lee JW; Han W
    Ann Surg Oncol; 2024 May; 31(5):3168-3176. PubMed ID: 38368292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the Necessity for Routine Sentinel Lymph Node Biopsy in Postmenopausal Patients Being Treated for Clinically Node Negative Breast Cancer the Era of RxPONDER.
    Davey MG; Kerin EP; McLaughlin RP; Barry MK; Malone CM; Elwahab SA; Lowery AJ; Kerin MJ
    Clin Breast Cancer; 2023 Jul; 23(5):500-507. PubMed ID: 37076364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Sentinel Lymph Node Biopsy on Female Patients With T3-4c Breast Cancer and 1-2 Positive Lymph Nodes: A Population-Based Cohort Study.
    Yang H; Sun Y; Wang P; Qiao J; Wang C; Liu Z
    Clin Breast Cancer; 2024 Apr; 24(3):e126-e137.e3. PubMed ID: 38114365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Merkel cell carcinoma: value of sentinel lymph-node status and adjuvant radiation therapy.
    Servy A; Maubec E; Sugier PE; Grange F; Mansard S; Lesimple T; Marinho E; Couturaud B; Girod A; Albert S; Dendale R; Calitchi E; Sarda L; Chanal J; Deschamps L; Sastre-Garau X; Laroche L; Crickx B; Avril MF
    Ann Oncol; 2016 May; 27(5):914-9. PubMed ID: 26811346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.